Drugs / FKS518
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04934072 | Jun 2021 → Aug 2023 | postmenopausal osteoporosis | Fresenius Kabi SwissBioSim GmbH | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FKS518 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04934072 ↗ |
| Route | Subcutaneous | “subcutaneously by single-use prefilled syringe (PFS)” NCT04934072 ↗ |